Corcept Therapeutics (CORT) Change in Acquisitions & Divestments (2017 - 2026)

Corcept Therapeutics (CORT) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $57.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 49.08% year-over-year to $57.1 million; the trailing twelve-month figure through Mar 2026 stood at $334.6 million (down 26.64% YoY), and the FY2025 full-year result was $389.6 million, down 5.64% from the prior year.
• Change in Acquisitions & Divestments slipped to $57.1 million in Q1 2026, from $132.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $207.5 million in Q1 2023 to a low of $42.1 million in Q1 2022.
• A 5-year average of $89.4 million and a median of $79.4 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 392.5% in 2023 and slumped 71.23% in 2025, its largest moves.
• Tracing CORT's Change in Acquisitions & Divestments over 5 years: stood at $79.4 million in 2022, then slumped by 40.83% to $47.0 million in 2023, then soared by 70.92% to $80.3 million in 2024, then surged by 64.37% to $132.0 million in 2025, then tumbled by 56.78% to $57.1 million in 2026.
• Business Quant data shows CORT's Change in Acquisitions & Divestments at $57.1 million in Q1 2026, $132.0 million in Q4 2025, and $52.0 million in Q3 2025.